Search Results - "Tisdale, James"
-
1
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management
Published in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (01-05-2016)“…Torsades de pointes (TdP) is a life-threatening arrhythmia associated with prolongation of the corrected QT (QTc) interval on the electrocardiogram. More than…”
Get full text
Book Review Journal Article -
2
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Published in Circulation (New York, N.Y.) (13-10-2020)“…Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous antiarrhythmic agents, antimicrobial drugs, psychotropic medications,…”
Get full text
Journal Article -
3
-
4
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published in Circulation (New York, N.Y.) (02-01-2024)“…The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of…”
Get full text
Journal Article -
5
Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction
Published in PloS one (19-08-2024)“…Heart failure (HF) with reduced ejection fraction (HFrEF) is a risk factor for drug-induced QT interval prolongation. It is unknown if HF with preserved…”
Get full text
Journal Article -
6
Editorial commentary: Amiodarone-induced thyroid diseases: Additional unintended consequences
Published in Trends in cardiovascular medicine (01-07-2019)“…[...]amiodarone increases mean serum digoxin concentrations by more than two-fold during concomitant administration [16]. [...]serum digoxin concentrations are…”
Get full text
Journal Article -
7
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
Published in Current medical research and opinion (01-12-2013)“…Abstract Objective: QT interval prolongation signifies an increased risk of the life-threatening arrhythmia torsades de pointes (TdP). The purpose of this…”
Get full text
Journal Article -
8
Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity
Published in Pharmacotherapy (01-05-2020)Get full text
Journal Article -
9
Prolonged Exposure to Remdesivir Inhibits the Human Ether-A-Go-Go-Related Gene Potassium Current
Published in Journal of cardiovascular pharmacology (01-09-2023)“…Remdesivir, approved for the treatment of COVID-19, has been associated with heart-rate corrected QT interval (QTc) prolongation and torsade de pointes in case…”
Get full text
Journal Article -
10
-
11
Development and validation of a risk score to predict QT interval prolongation in hospitalized patients
Published in Circulation Cardiovascular quality and outcomes (01-07-2013)“…Identifying hospitalized patients at risk for QT interval prolongation could lead to interventions to reduce the risk of torsades de pointes. Our objective was…”
Get full text
Journal Article -
12
Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review
Published in Pharmacotherapy (01-08-2018)“…Prolongation of the heart rate–corrected QT (QTc) interval increases the risk for torsade de pointes (TdP), a potentially fatal arrhythmia. The likelihood of…”
Get full text
Journal Article -
13
Prevalence and significance of acquired QT interval prolongation in hospitalized patients
Published in Heart rhythm (01-07-2017)Get full text
Journal Article -
14
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published in Journal of the American College of Cardiology (02-01-2024)“…The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" provides recommendations to guide clinicians in the…”
Get full text
Journal Article -
15
Editorial Commentary: Optimization of dose selection for nonvitamin K antagonist oral anticoagulants
Published in Trends in cardiovascular medicine (01-11-2017)“…Inappropriate NOAC doses are administered too commonly, which may result in bleeding (in the case of higher than recommended doses in patients with kidney…”
Get full text
Journal Article -
16
Navigating the Minefield of QTc Interval‐Prolonging Therapy in Nursing Facility Residents
Published in Journal of the American Geriatrics Society (JAGS) (01-07-2019)“…BACKGROUND The exponential increase in the number of medications associated with clinically important prolongation of the heart rate‐corrected QT interval…”
Get full text
Journal Article -
17
Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction
Published in International journal of cardiology (01-01-2025)“…Heart failure (HF) with preserved ejection fraction (HFpEF) is associated with enhanced response to drug-induced QT interval lengthening. We determined the…”
Get full text
Journal Article -
18
Multidisciplinary Critical Care Management of Electrical Storm: JACC State-of-the-Art Review
Published in Journal of the American College of Cardiology (06-06-2023)“…Electrical storm (ES) reflects life-threatening cardiac electrical instability with 3 or more ventricular arrhythmia episodes within 24 hours. Identification…”
Get full text
Journal Article -
19
Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association
Published in Circulation (New York, N.Y.) (05-03-2024)“…Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the immature myocardium, the hemodynamic consequences of either…”
Get full text
Journal Article -
20